Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Psychosomatics. 2019 May 28;60(6):563–573. doi: 10.1016/j.psym.2019.05.002

Table 1.

Descriptive Characteristics of the Sample

Total N 552 % 100
Sex
    Female 311 56.3
    Male 241 46.3
Race/Ethnicity
 White, Non-Hispanic 424 76.8
 Black, Non-Hispanic 70 12.7
 Hispanic 60 10.9
 Asian 21 3.8
 Native Hawaiian / Pacific Islander 1 0.2
 Other 21 3.8
Age
 18–39 164 29.7
 40–64 231 41.8
 65+ 157 28.4
Primary diagnosis
 Bipolar I disorder 296 53.6
 Bipolar II disorder 76 13.7
 Unspecified Bipolar disorder /Bipolar disorder not otherwise specified 180 32.6
Comorbid medical conditions1
 Cardiovascular disease 361 65.4
 Fluid or electrolyte disorder 230 41.7
 Anemia 171 31.0
 Neurological disorder 136 24.6
 Chronic Obstructive Pulmonary Disease 134
24.3
Elixhauser comorbidity index2
 ≥10 181 32.8
 6–9 104 18.8
 ≤5 151 27.3
Substance use disorder
 Drug abuse 141 28.6
 Alcohol abuse 84 15.2
 Nicotine use 102 18.4
Transfer from medicine to psychiatry 201 36.4
1

Rates of common comorbid conditions are presented in further detail in Supplementary Figure 1.

2

Elixhauser comorbidity index is condensed to a single numeric score that summarizes disease burden using the Van Walraven system (29). This score discriminates risk of in-hospital mortality. Scores ≤ 5 correspond to an in-hospital mortality risk of approximately 0-5%, scores 6–9 a mortality risk of approximately 5–10%, and scores ≥ 10 a mortality risk of greater than 10%. This score was unable to be calculated for N=116 due to missing data.